You are here: Home > About us > Our organisation > Optometry Australia > Our current focus: strategic plan > Securing an expanded Medicare schedule

Working to improve the MBS

Optometry Australia is focused on securing a Medicare Benefits Schedule (MBS) that enables patients to access the primary eye care they need within a system that supports sustainable optometry practices.

We have prioritised advocating for:

  • the reinstatement of indexation to optometry items
  • the reinstatement of rebates for biennial initial comprehensive examinations for all middle-aged Australians
  • fairer rebates for all items that better reflect the cost of providing quality care.

We are pleased that, following our advocacy, the Government has committed to reinstating indexation from 1 July 2019, and that the Optometry Clinical Committee of the MBS Review Taskforce has recommended that all middle-aged Australians be able to access a rebate for a comprehensive examination from an optometrists every two years.

A review of the full Medicare Benefit Schedule (MBS) has been underway since 2015, focused on ensuring that the Schedule aligns with contemporary clinical evidence and practice. In late 2018 the Optometry Clinical Committee was convened to review the optometry items on the Schedule.

We have proactively advocated recommendations to the Committee, many of which have been included in the Committee’s recommendations to the MBS Review Taskforce. We have worked with a member advisory group to provide comprehensive verbal and written submissions to the Taskforce’s consultation regarding the Committee’s recommendations, and made ourselves available for further consultation with the Taskforce prior to them submitting their recommendations to the Government.

You might be interested in

Vale Peter Swann

We are saddened to learn of the passing of Professor Peter Swann, a well-respected educator and leader within the sector. Revered for his extensive knowledge of clinical optometry, he was greatly admired by his students and colleagues and will be remembered for his many contributions to optometry and academia.
Vale Peter Swann View